Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Orvosi Hetilap
|
October 17, 2001
[Gastrointestinal side effects of non-steroidal anti-inflammatory drugs in high-risk patients--role of selective cyclooxygenase inhibitors]
L Prónai
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1991
Protective effect of carboxyethylgermanium sesquioxide (Ge-132) on superoxide generation by 60Co-irradiated leukocytes
L Prónai, S Arimori
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1992
Decreased plasma superoxide scavenging activity in immunological disorders--carboxyethylgermanium sesquioxide (Ge-132) as a promoter of prednisolone
L Prónai, S Arimori
Orvosi Hetilap
|
December 8, 1996
[Possibilities of drug therapy of acute hemorrhage of the upper digestive system]
L Prónai, Z Tulassay
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1991
BG-104 enhances the decreased plasma superoxide scavenging activity in patients with Behçet's disease, Sjögren's syndrome or hematological malignancy
L Prónai, S Arimori
Orvosi Hetilap
|
June 27, 1993
[Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use]
J Fehér, L Prónai
Orvosi Hetilap
|
March 28, 1993
[The role of free radical scavengers in gastrointestinal diseases]
J Fehér, L Prónai
The American Journal of Gastroenterology
|
February 18, 1999
Do we all treat functional dyspepsia with Helicobacter pylori eradication?
L Prónai, F Szalay, Z Tulassay
Endoscopy
|
May 1, 1993
Difficulty in early detection of gastric cancer--a case of gastric cancer with metastasis of the liver, peritoneum and intraabdominal lymph nodes
K Iwamura, H Niki, L Prónai
Orvosi Hetilap
|
August 4, 1996
[Nitric oxide. Basic research and possible clinical use]
L Prónai, E Szaleczky, J Fehér
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Orvosi Hetilap
|
October 17, 2001
[Gastrointestinal side effects of non-steroidal anti-inflammatory drugs in high-risk patients--role of selective cyclooxygenase inhibitors]
L Prónai
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1991
Protective effect of carboxyethylgermanium sesquioxide (Ge-132) on superoxide generation by 60Co-irradiated leukocytes
L Prónai, S Arimori
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1992
Decreased plasma superoxide scavenging activity in immunological disorders--carboxyethylgermanium sesquioxide (Ge-132) as a promoter of prednisolone
L Prónai, S Arimori
Orvosi Hetilap
|
December 8, 1996
[Possibilities of drug therapy of acute hemorrhage of the upper digestive system]
L Prónai, Z Tulassay
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1991
BG-104 enhances the decreased plasma superoxide scavenging activity in patients with Behçet's disease, Sjögren's syndrome or hematological malignancy
L Prónai, S Arimori
Orvosi Hetilap
|
June 27, 1993
[Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use]
J Fehér, L Prónai
Orvosi Hetilap
|
March 28, 1993
[The role of free radical scavengers in gastrointestinal diseases]
J Fehér, L Prónai
The American Journal of Gastroenterology
|
February 18, 1999
Do we all treat functional dyspepsia with Helicobacter pylori eradication?
L Prónai, F Szalay, Z Tulassay
Endoscopy
|
May 1, 1993
Difficulty in early detection of gastric cancer--a case of gastric cancer with metastasis of the liver, peritoneum and intraabdominal lymph nodes
K Iwamura, H Niki, L Prónai
Orvosi Hetilap
|
August 4, 1996
[Nitric oxide. Basic research and possible clinical use]
L Prónai, E Szaleczky, J Fehér
Page
of 4